Research Article

Representative Stock Analysis in Chinese Medical Industry and Relevant Investment Recommendations

Authors

  • Zhang Jingyi Faculty of Business Administration, University of Macao, Macao, China

Abstract

As one of the most significant pillar industries of China, the medical industry can improve the quality of our lives in many aspects; it is also beneficial to the development of the national economy. After the outbreak of COVID-19, the function of the medical industry was further displayed. This paper is aimed at analyzing some representative stocks in the Chinese medical industry by using fundamental analysis and making recommendations for investors based on the analysis results, and reach a conclusion that investing in stocks in the medical industry is a reasonable choice, and investors had better combine of the absolute valuation results with the relative valuation results while making investment decisions so that some cognitive biases could be avoided.

Article information

Journal

Journal of Economics, Finance and Accounting Studies

Volume (Issue)

5 (2)

Pages

139-151

Published

2023-04-18

How to Cite

Jingyi, Z. (2023). Representative Stock Analysis in Chinese Medical Industry and Relevant Investment Recommendations. Journal of Economics, Finance and Accounting Studies, 5(2), 139–151. https://doi.org/10.32996/jefas.2023.5.2.11

Downloads

Keywords:

DDM, DCF, P/E ratio, EV/EBITDA ratio